药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Amifampridine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Amifampridine.
Trilostane
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dexchlorpheniramine maleate.
Trilostane
Benidipine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Benidipine.
Trilostane
Melperone
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Melperone.
Trilostane
Lenvatinib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lenvatinib.
Trilostane
Ceritinib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Ceritinib.
Trilostane
Butriptyline
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Butriptyline.
Trilostane
Eperisone
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Eperisone.
Trilostane
Fendiline
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Fendiline.
Trilostane
Bedaquiline
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Bedaquiline.
Trilostane
Antazoline
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Antazoline.
Trilostane
Nilvadipine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nilvadipine.
Trilostane
Panobinostat
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Panobinostat.
Trilostane
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Nemonoxacin.
Trilostane
Telavancin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Telavancin.
Trilostane
Tucidinostat
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tucidinostat.
Trilostane
Tedisamil
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tedisamil.
Trilostane
Garenoxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Garenoxacin.
Trilostane
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Technetium Tc-99m ciprofloxacin.
Trilostane
Pracinostat
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pracinostat.